STAT Plus: In the race for a Covid-19 vaccine, Pfizer turns to a scientist with a history of defying skeptics — and getting results
For the pharma behemoth Pfizer, the race to develop a Covid-19 vaccine is not just about bringing a quick end to the global pandemic. It’s also about the company’s reputation among scientists, politicians, and the public, and it’s about pride: demonstrating that one of the world’s biggest drug makers is as nimble — and more formidable — than any upstart biotech.
Pfizer and that upstart rival, Moderna, were the first companies to launch large clinical trials to prove their vaccines’ efficacy, and on the same day: July 27. They have been in a neck-and-neck competition ever since.
